Navidea Biopharmaceuticals Current Ratio 2006-2019 | NAVB
Navidea Biopharmaceuticals current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Navidea Biopharmaceuticals Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-09-30 | $0.00B | $0.00B | 0.90 |
| 2019-06-30 | $0.01B | $0.00B | 1.69 |
| 2019-03-31 | $0.00B | $0.00B | 0.95 |
| 2018-12-31 | $0.01B | $0.00B | 1.66 |
| 2018-09-30 | $0.01B | $0.01B | 1.22 |
| 2018-06-30 | $0.01B | $0.01B | 1.43 |
| 2018-03-31 | $0.02B | $0.01B | 1.35 |
| 2017-12-31 | $0.01B | $0.01B | 1.71 |
| 2017-09-30 | $0.02B | $0.01B | 2.58 |
| 2017-06-30 | $0.02B | $0.01B | 2.13 |
| 2017-03-31 | $0.02B | $0.01B | 2.18 |
| 2016-12-31 | $0.01B | $0.07B | 0.16 |
| 2016-09-30 | $0.01B | $0.06B | 0.15 |
| 2016-06-30 | $0.01B | $0.06B | 0.11 |
| 2016-03-31 | $0.01B | $0.06B | 0.18 |
| 2015-12-31 | $0.01B | $0.01B | 2.03 |
| 2015-09-30 | $0.02B | $0.01B | 2.40 |
| 2015-06-30 | $0.02B | $0.01B | 3.50 |
| 2015-03-31 | $0.01B | $0.01B | 0.62 |
| 2014-12-31 | $0.01B | $0.01B | 0.95 |
| 2014-09-30 | $0.01B | $0.01B | 1.68 |
| 2014-06-30 | $0.02B | $0.01B | 3.34 |
| 2014-03-31 | $0.03B | $0.01B | 5.42 |
| 2013-12-31 | $0.04B | $0.01B | 3.31 |
| 2013-09-30 | $0.05B | $0.01B | 7.55 |
| 2013-06-30 | $0.03B | $0.01B | 6.09 |
| 2013-03-31 | $0.01B | $0.01B | 2.07 |
| 2012-12-31 | $0.01B | $0.01B | 1.72 |
| 2012-09-30 | $0.01B | $0.01B | 1.74 |
| 2012-06-30 | $0.02B | $0.01B | 3.34 |
| 2012-03-31 | $0.02B | $0.01B | 4.78 |
| 2011-12-31 | $0.03B | $0.00B | 8.97 |
| 2011-09-30 | $0.03B | $0.00B | 7.87 |
| 2011-06-30 | $0.01B | $0.01B | 2.28 |
| 2011-03-31 | $0.01B | $0.00B | 2.99 |
| 2010-12-31 | $0.01B | $0.00B | 2.59 |
| 2010-09-30 | $0.01B | $0.00B | 1.64 |
| 2010-06-30 | $0.01B | $0.00B | 2.41 |
| 2010-03-31 | $0.01B | $0.00B | 2.54 |
| 2009-12-31 | $0.01B | $0.00B | 3.59 |
| 2009-09-30 | $0.01B | $0.00B | 3.55 |
| 2009-06-30 | $0.01B | $0.00B | 2.79 |
| 2009-03-31 | $0.01B | $0.00B | 3.02 |
| 2008-12-31 | $0.01B | $0.00B | 3.12 |
| 2008-09-30 | $0.01B | $0.00B | 2.32 |
| 2008-06-30 | $0.01B | $0.00B | 3.55 |
| 2008-03-31 | $0.00B | $0.00B | 2.18 |
| 2007-12-31 | $0.01B | $0.00B | 2.14 |
| 2007-09-30 | $0.00B | $0.01B | 0.65 |
| 2007-06-30 | $0.00B | $0.01B | 0.80 |
| 2007-03-31 | $0.00B | $0.01B | 0.90 |
| 2006-12-31 | $0.01B | $0.00B | 1.56 |
| 2006-09-30 | $0.01B | $0.00B | 5.27 |
| 2006-06-30 | $0.01B | $0.00B | 7.46 |
| 2006-03-31 | $0.01B | $0.00B | 6.42 |
| 2005-12-31 | $0.01B | $0.00B | 5.63 |
| 2005-09-30 | $0.01B | $0.00B | 8.71 |
| 2005-06-30 | $0.01B | $0.00B | 8.05 |
| 2005-03-31 | $0.01B | $0.00B | 10.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.007B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $118.681B | 24.58 |
| Intuitive Surgical (ISRG) | United States | $63.491B | 49.90 |
| Edwards Lifesciences (EW) | United States | $49.921B | 45.33 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.137B | 14.98 |
| IDEXX Laboratories (IDXX) | United States | $22.090B | 53.42 |
| Olympus (OCPNY) | Japan | $21.701B | 162.97 |
| DexCom (DXCM) | United States | $18.868B | 168.97 |
| Teleflex (TFX) | United States | $15.367B | 31.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.903B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.384B | 38.72 |
| STERIS (STE) | Ireland | $12.344B | 27.27 |
| Hologic (HOLX) | United States | $12.336B | 18.91 |
| Varian Medical Systems (VAR) | United States | $11.335B | 26.83 |
| ABIOMED (ABMD) | United States | $10.094B | 54.92 |
| Masimo (MASI) | United States | $7.778B | 46.44 |
| Penumbra (PEN) | United States | $5.832B | 189.81 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Elekta AB (EKTAY) | Sweden | $5.597B | 43.09 |
| Globus Medical (GMED) | United States | $5.474B | 33.89 |
| Integra LifeSciences Holdings (IART) | United States | $5.013B | 21.54 |
| Wright Medical Group (WMGI) | Netherlands | $3.731B | 326.67 |
| LivaNova (LIVN) | United Kingdom | $3.686B | 26.54 |
| Tandem Diabetes Care (TNDM) | United States | $3.630B | 0.00 |
| Nevro (NVRO) | United States | $3.226B | 0.00 |
| Cantel Medical (CMD) | United States | $3.043B | 30.73 |
| Integer Holdings (ITGR) | United States | $2.478B | 16.96 |
| Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
| Glaukos (GKOS) | United States | $2.339B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.620B | 31.88 |
| Inogen (INGN) | United States | $1.519B | 47.95 |
| Veracyte (VCYT) | United States | $1.159B | 0.00 |
| Natus Medical (NTUS) | United States | $1.117B | 26.85 |
| Silk Road Medical (SILK) | United States | $1.098B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.016B | 37.67 |
| Tactile Systems Technology (TCMD) | United States | $1.005B | 114.78 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Luminex (LMNX) | United States | $0.902B | 0.00 |
| CryoLife (CRY) | United States | $0.882B | 90.46 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.857B | 28.46 |
| Accelerate Diagnostics (AXDX) | United States | $0.839B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.704B | 0.00 |
| Intersect ENT (XENT) | United States | $0.658B | 0.00 |
| AxoGen (AXGN) | United States | $0.608B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.577B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.564B | 20.24 |
| Quotient (QTNT) | Switzerland | $0.540B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.445B | 13.45 |
| Si-Bone (SIBN) | United States | $0.435B | 0.00 |
| Sientra (SIEN) | United States | $0.425B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.421B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.328B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.297B | 41.36 |
| IRadimed (IRMD) | United States | $0.275B | 38.56 |
| SeaSpine Holdings (SPNE) | United States | $0.251B | 0.00 |
| ViewRay (VRAY) | United States | $0.244B | 0.00 |
| Accuray (ARAY) | United States | $0.239B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.231B | 64.40 |
| Stereotaxis (STXS) | United States | $0.223B | 0.00 |
| Fluidigm (FLDM) | United States | $0.165B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.148B | 40.20 |
| ConforMIS (CFMS) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 66.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.090B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.087B | 0.00 |
| TransEnterix (TRXC) | United States | $0.078B | 0.00 |
| Vermillion (VRML) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Electromed (ELMD) | United States | $0.060B | 21.51 |
| Apollo Endosurgery (APEN) | United States | $0.059B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.054B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.046B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.042B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.028B | 0.00 |
| Nuvectra (NVTR) | United States | $0.025B | 0.00 |
| Neovasc (NVCN) | Canada | $0.023B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.023B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.021B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.020B | 0.00 |
| Restoration Robotics (VERO) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.50 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.011B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.011B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| InspireMD (NSPR) | Israel | $0.001B | 0.00 |
